Kokoro (Aframomum melegueta) — Hermetica Encyclopedia
Herbs (Global Traditional) · African

Kokoro (Aframomum melegueta) (Aframomum melegueta)

Moderate Evidencebotanical2 PubMed Studies

Hermetica Superfood Encyclopedia

The Short Answer

Aframomum melegueta (grains of paradise) contains bioactive compounds including 6-paradol and flavonoids that may help regulate blood sugar by inhibiting α-amylase and α-glucosidase enzymes. The seed extract shows preliminary antioxidant properties through its rutin, epicatechin, and kaempferol content.

2
PubMed Studies
0
Validated Benefits
Synergy Pairings
At a Glance
CategoryHerbs (Global Traditional)
GroupAfrican
Evidence LevelModerate
Primary KeywordAframomum melegueta benefits
Synergy Pairings3
Kokoro close-up macro showing natural texture and detail — rich in thermogenic, antioxidant, anti-inflammatory
Kokoro (Aframomum melegueta) — botanical close-up

Health Benefits

Origin & History

Kokoro growing in Africa — natural habitat
Natural habitat

Aframomum melegueta, known as grains of paradise or kokoro, is a perennial herb in the ginger family native to West Africa, particularly Ghana, Nigeria, and Liberia, where its pungent seeds are harvested as the primary medicinal part. The seeds are processed through methanol Soxhlet extraction, hydro-distillation, or ethanol extraction to yield bioactive compounds including gingerols, shogaols, and paradols.

In West African traditional medicine, particularly in Ghana and Nigeria, Aframomum melegueta seeds have been used for centuries as both a spice and remedy for inflammation, diabetes, infections, and digestive issues. Historical applications include anti-cancer, hepato-protective, and body fat-lowering effects in African herbal practices.Traditional Medicine

Scientific Research

Currently, no human clinical trials, RCTs, or meta-analyses have been conducted on Aframomum melegueta. Available evidence is limited to in vitro, computational modeling, and animal studies, with human validation still needed.

Preparation & Dosage

Kokoro prepared as liquid extract — pairs with Ginger, Turmeric, Cinnamon
Traditional preparation

No clinically studied dosage ranges are available from human trials. Extracts are often standardized to 6-paradol (30.5%), 6-gingerol (19.5%), or 6-shogaol (12.5%) content, but specific therapeutic doses remain unestablished. Consult a healthcare provider before starting any new supplement.

Nutritional Profile

{"macronutrients": {"fiber": "approximately 8-10g/100g"}, "micronutrients": {"vitamins": {"vitamin C": "trace amounts"}, "minerals": {"potassium": "around 300mg/100g", "calcium": "approximately 20mg/100g", "magnesium": "approximately 40mg/100g"}}, "bioactive_compounds": {"flavonoids": {"rutin": "4.02-24.56 mg/100g", "epicatechin": "present", "kaempferol": "present"}, "terpenes": {"\u03b1-humulene": "present", "\u03b2-caryophyllene": "present"}}, "bioavailability_notes": "The bioavailability of flavonoids and terpenes may vary based on preparation and individual absorption factors."}

How It Works

Mechanism of Action

Aframomum melegueta's primary bioactive compound 6-paradol inhibits carbohydrate-digesting enzymes α-amylase and α-glucosidase, potentially slowing glucose absorption. The flavonoid compounds rutin, epicatechin, and kaempferol provide antioxidant activity by scavenging free radicals and reducing oxidative stress markers. These mechanisms may contribute to improved glucose metabolism and cellular protection.

Clinical Evidence

Current evidence for Aframomum melegueta is limited to preliminary in vitro studies examining enzyme inhibition and antioxidant capacity. Laboratory analyses have quantified flavonoid content at 4.02-24.56 mg/100g, with rutin being the predominant compound. No human clinical trials have been conducted to establish therapeutic efficacy, safety profiles, or optimal dosing regimens. The existing research represents early-stage investigation requiring substantial clinical validation.

Safety & Interactions

Safety data for Aframomum melegueta supplementation is extremely limited due to lack of human studies. As a member of the ginger family, it may potentially interact with anticoagulant medications or affect blood sugar levels in diabetic patients. Pregnant and breastfeeding women should avoid supplementation due to insufficient safety data. Individuals with bleeding disorders or scheduled for surgery should exercise caution given potential effects on blood clotting.

Synergy Stack

Hermetica Formulation Heuristic

Also Known As

Aframomum meleguetaGrains of ParadiseGuinea GrainsAlligator PepperMelegueta PepperGuinea PepperParadise SeedsAtare

Frequently Asked Questions

What is the active compound in Aframomum melegueta?
The primary bioactive compound is 6-paradol, which demonstrates enzyme inhibitory activity against α-amylase and α-glucosidase. The seeds also contain flavonoids including rutin (the most abundant), epicatechin, and kaempferol at concentrations of 4.02-24.56 mg/100g.
How does Aframomum melegueta affect blood sugar?
Preliminary in vitro studies suggest it may help regulate blood sugar by inhibiting α-amylase and α-glucosidase enzymes that break down carbohydrates. This enzyme inhibition could theoretically slow glucose absorption, though human clinical trials are needed to confirm this effect.
Is Aframomum melegueta the same as grains of paradise?
Yes, Aframomum melegueta is commonly known as grains of paradise or melegueta pepper. It's a spice native to West Africa that belongs to the ginger family (Zingiberaceae) and has been used traditionally as both a culinary spice and medicinal plant.
What's the recommended dosage for Aframomum melegueta?
No standardized dosage has been established for Aframomum melegueta supplements due to lack of human clinical trials. The existing research is limited to laboratory studies analyzing compound content and in vitro enzyme activity, making dosage recommendations premature without safety and efficacy data.
Can diabetics take Aframomum melegueta supplements?
Diabetics should consult healthcare providers before using Aframomum melegueta supplements due to potential blood sugar effects and lack of human safety data. The preliminary enzyme inhibition research suggests it could theoretically affect glucose metabolism, potentially interacting with diabetes medications.
Does Aframomum melegueta interact with diabetes medications like metformin or insulin?
While Aframomum melegueta may have blood sugar-lowering properties through enzyme inhibition, clinical interaction data with specific diabetes medications is limited. If you are taking metformin, insulin, or other glucose-control medications, consult your healthcare provider before adding this supplement, as combined effects could potentially lower blood sugar too much. No serious interactions have been documented in available literature, but medical supervision is prudent for concurrent use.
Is Aframomum melegueta safe during pregnancy and breastfeeding?
There is insufficient clinical safety data on Aframomum melegueta use during pregnancy or breastfeeding to establish clear recommendations. Traditional use in West African cuisines at culinary spice levels is generally considered safe, but concentrated supplemental doses have not been adequately studied in these populations. Pregnant or breastfeeding individuals should consult a healthcare provider before supplementing.
What does the research evidence actually show about Aframomum melegueta's anti-inflammatory effects?
Current evidence for anti-inflammatory activity relies primarily on computational studies and in vitro laboratory research rather than human clinical trials. The identified compounds (α-humulene and β-caryophyllene) show theoretical anti-inflammatory potential, but their bioavailability and efficacy in the human body remain unproven. More rigorous human studies are needed before making definitive claims about anti-inflammatory benefits in supplement form.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.